Aragen Life Sciences IPO Plans $160.5m Expansion

Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.

By ·

Nov 18, 2026

3 cards · 40s · tap to begin

From · · · 40s

Aragen Life Sciences IPO Plans $160.5m Expansion

Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.

In brief

Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut. Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO. Originally reported by The…

IPO-bound Aragen expansion plans

Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.

Investment breakdown

Rs 10 billion for contract development and Rs 4 billion for discovery research.

Capacity expansion targets

Small molecules capacity to 650 kilolitres; biologics to 8.5 kilolitres by next year.

The one thing

Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO.

Read the original on The Economic Times

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on aragen life sciences and related topics.